• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肌少症性肥胖发生相关因素的识别:文献综述与专家小组投票

Identification of factors associated with sarcopenic obesity development: Literature review and expert panel voting.

作者信息

Pinel A, Guillet C, Capel F, Pouget M, De Antonio M, Pereira B, Topinkova E, Eglseer D, Barazzoni R, Cruz-Jentoft A J, Schoufour J D, Weijs P J M, Boirie Y

机构信息

University of Clermont Auvergne, Human Nutrition Unit, INRAe, CRNH Auvergne, Clermont-Ferrand, France.

University of Clermont Auvergne, Human Nutrition Unit, INRAe, CRNH Auvergne, Clermont-Ferrand, France.

出版信息

Clin Nutr. 2024 Jun;43(6):1414-1424. doi: 10.1016/j.clnu.2024.04.033. Epub 2024 Apr 24.

DOI:10.1016/j.clnu.2024.04.033
PMID:38701709
Abstract

Sarcopenic obesity (SO) is defined as the combination of excess fat mass (obesity) and low skeletal muscle mass and function (sarcopenia). The identification and classification of factors related to SO would favor better prevention and diagnosis. The present article aimed to (i) define a list of factors related with SO based on literature analysis, (ii) identify clinical conditions linked with SO development from literature search and (iii) evaluate their relevance and the potential research gaps by consulting an expert panel. From 4746 articles screened, 240 articles were selected for extraction of the factors associated with SO. Factors were classified according to their frequency in the literature. Clinical conditions were also recorded. Then, they were evaluated by a panel of expert for evaluation of their relevance in SO development. Experts also suggested additional factors. Thirty-nine unique factors were extracted from the papers and additional eleven factors suggested by a panel of experts in the SO field. The frequency in the literature showed insulin resistance, dyslipidemia, lack of exercise training, inflammation and hypertension as the most frequent factors associated with SO whereas experts ranked low spontaneous physical activity, protein and energy intakes, low exercise training and aging as the most important. Although literature and expert panel presented some differences, this first list of associated factors could help to identify patients at risk of SO. Further work is needed to confirm the contribution of factors associated with SO among the population overtime or in randomized controlled trials to demonstrate causality.

摘要

肌少症性肥胖(SO)被定义为过量脂肪量(肥胖)与低骨骼肌量和功能(肌少症)的结合。识别和分类与SO相关的因素将有助于更好地预防和诊断。本文旨在:(i)基于文献分析确定与SO相关的因素列表;(ii)通过文献检索确定与SO发生相关的临床情况;(iii)通过咨询专家小组评估这些因素的相关性以及潜在的研究空白。在筛选的4746篇文章中,选取了240篇用于提取与SO相关的因素。根据这些因素在文献中的出现频率进行分类,同时记录临床情况。然后,由一个专家小组对其在SO发生中的相关性进行评估。专家们还提出了其他因素。从论文中提取了39个独特的因素,并由SO领域的专家小组另外提出了11个因素。文献中的出现频率显示,胰岛素抵抗、血脂异常、缺乏运动训练、炎症和高血压是与SO相关的最常见因素,而专家们认为低自发体力活动、蛋白质和能量摄入、低运动训练以及衰老最为重要。尽管文献和专家小组的意见存在一些差异,但这一相关因素的初步列表有助于识别有SO风险的患者。需要进一步开展工作,以确认在人群中长期或在随机对照试验中与SO相关的因素的作用,从而证明因果关系。

相似文献

1
Identification of factors associated with sarcopenic obesity development: Literature review and expert panel voting.与肌少症性肥胖发生相关因素的识别:文献综述与专家小组投票
Clin Nutr. 2024 Jun;43(6):1414-1424. doi: 10.1016/j.clnu.2024.04.033. Epub 2024 Apr 24.
2
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.定义和诊断肌少症性肥胖的标准:ESPEN 和 EASO 共识声明。
Obes Facts. 2022;15(3):321-335. doi: 10.1159/000521241. Epub 2022 Feb 23.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
5
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
6
Factors that influence participation in physical activity for people with bipolar disorder: a synthesis of qualitative evidence.影响双相障碍患者参与体育活动的因素:定性证据的综合分析。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013557. doi: 10.1002/14651858.CD013557.pub2.
7
Exercise alone or combined with dietary supplements for sarcopenic obesity in community-dwelling older people: A systematic review of randomized controlled trials.单独运动或与饮食补充剂联合用于社区居住的老年肌少症肥胖:随机对照试验的系统评价。
Maturitas. 2018 Apr;110:92-103. doi: 10.1016/j.maturitas.2018.02.005. Epub 2018 Feb 13.
8
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
9
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
10
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.

引用本文的文献

1
Exercise interventions of ≥8 weeks improve body composition, physical function, metabolism, and inflammation in older adults with stage sarcopenic obesity: a systematic review and meta-analysis.为期≥8周的运动干预可改善患有II期肌肉减少性肥胖的老年人的身体成分、身体功能、新陈代谢和炎症:一项系统评价和荟萃分析。
Front Nutr. 2025 Aug 12;12:1575580. doi: 10.3389/fnut.2025.1575580. eCollection 2025.
2
The Role of Rehabilitation Program in Managing the Triad of Sarcopenia, Obesity, and Chronic Pain.康复计划在管理肌肉减少症、肥胖症和慢性疼痛三联征中的作用。
Life (Basel). 2025 Jul 24;15(8):1174. doi: 10.3390/life15081174.
3
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation.
减肥期间优化身体成分:氨基酸补充剂的作用。
Nutrients. 2025 Jun 13;17(12):2000. doi: 10.3390/nu17122000.
4
Metabolic and Inflammatory Biomarkers Predicting Sarcopenic Obesity and Cardiometabolic Risk in Arab Women: A Cross-Sectional Study.代谢和炎症生物标志物预测阿拉伯女性肌肉减少性肥胖和心血管代谢风险:一项横断面研究
Int J Mol Sci. 2025 Jun 13;26(12):5699. doi: 10.3390/ijms26125699.
5
Significant Published Articles in 2024 for Pharmacy Nutrition Support Practice.2024年药学营养支持实践领域的重要已发表文章。
Hosp Pharm. 2025 May 20:00185787251337596. doi: 10.1177/00185787251337596.
6
Identifying Key Predictors of Sarcopenic Obesity in Italian Severely Obese Older Adults: Deep Learning Approach.识别意大利重度肥胖老年人肌少症肥胖的关键预测因素:深度学习方法。
J Clin Med. 2025 Apr 29;14(9):3069. doi: 10.3390/jcm14093069.
7
Sarcopenic obesity and weight loss-induced muscle mass loss.肌少性肥胖与体重减轻引起的肌肉量减少。
Curr Opin Clin Nutr Metab Care. 2025 Jul 1;28(4):339-350. doi: 10.1097/MCO.0000000000001131. Epub 2025 Apr 29.
8
Bridging the Gap: Supplements Strategies from Experimental Research to Clinical Applications in Sarcopenic Obesity.弥合差距:从肌肉减少性肥胖的实验研究到临床应用的补充策略
Curr Issues Mol Biol. 2024 Nov 24;46(12):13418-13430. doi: 10.3390/cimb46120800.
9
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia based on NHANES.基于美国国家健康与营养检查调查(NHANES)的非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值和肌肉减少症之间的关联
Sci Rep. 2024 Dec 4;14(1):30166. doi: 10.1038/s41598-024-81830-z.
10
Update on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management.肥胖与心血管风险更新:从病理生理学到临床管理。
Nutrients. 2024 Aug 20;16(16):2781. doi: 10.3390/nu16162781.